Gregory M. Weinhoff - 30 Jun 2024 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Business Officer
Signature
/s/ Gregory M. Weinhoff
Issuer symbol
CNTA
Transactions as of
30 Jun 2024
Net transactions value
-$106,030
Form type
4
Filing time
02 Jul 2024, 16:33:25 UTC
Previous filing
02 Apr 2024
Next filing
23 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $106,030 -11,742 -4.4% $9.03 253,369 30 Jun 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.